🇺🇸 FDA
Pipeline program

Gemcitabine 100 mg/ml Concentrate for Solution for Infusion, 9-ING-41, Abraxane 5 mg/ml powder for dispersion for infusion.

1801

Phase 2 small_molecule active

Quick answer

Gemcitabine 100 mg/ml Concentrate for Solution for Infusion, 9-ING-41, Abraxane 5 mg/ml powder for dispersion for infusion. for Refractory Hematologic Malignancies or Solid Tumors is a Phase 2 program (small_molecule) at ACTUATE THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ACTUATE THERAPEUTICS, INC.
Indication
Refractory Hematologic Malignancies or Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials